This online, OnDemand educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards of Commercial Support by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty, and others in the planning and control of continuing medical education (CME) activities to disclose all their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education. Any relevant conflicts of interest have been mitigated.
Statement on off-label and investigational use: Faculty are asked to make a reasonable effort to identify during their presentation any discussion of off-label or investigative use or application of a product or device.
Saima Aslam, MBBS:
Scientific Consultant/Advisor: Phico, Phiogen, Rocket Pharmaceuticals, BioMx, Pherecydes
Research Grants: Contrafect, Armata
David N. Assis, MD:
Research Grant: Gilead
Scott W. Biggins, MD, MAS, FAASLD:
Research Grant: Salix
Robert S. Brown, Jr, MD, MPH, FAASLD:
Scientific Consultant/Advisor: Gilead, AbbVie, Intercept Pharmaceuticals, Salix, Mallinkrodt, eGenesis, Madrigal
Research Grants: Gilead, AbbVie, Enanta, Intercept, Mirum
Lily Dara, MD:
Scientific Consultant/Advisor: Intercept Pharmaceuticals
Research Grant: Intercept Pharmaceuticals
Oren K. Fix, MD, MSc, FAASLD:
Nothing to Disclose.
David Goldberg, MD, MSCE:
Scientific Consultant/Advisor: Pfizer, Inc
Julie Heimbach, MD, FAASLD:
Nothing to Disclose.
Christopher B. Hughes, MD, FACS:
Nothing to Disclose.
Lindsay Y. King, MD:
Nothing to Disclose.
Tatyana Kushner, MD, MSCE:
Scientific Consultant/Advisor: Gilead, HDV, AbbVie, GlaxoSmithKline
Advisory Board: Gilead
Research Grant: Gilead
Jennifer C. Lai, MD, MBA:
Scientific Consultant/Advisor: GenFit, Boehringer/Ingelheim, NovoNordisk
Research Grants: CymaBay, AcellaHealth Inc, Lipocine, Gore Medical Vir Biotechnology
Anne M. Larson, MD, FAASLD:
Royalties/Patents: UpToDate
Nathaly P. Llore, MD:
Nothing to Disclose.
Mercedes Martinez, MD:
Nothing to Disclose.
Jessica L. Mellinger, MD:
Scientific Consultant: GlaxoSmithKline
Amrita Narang, MD MPH:
Scientific Consultant/Advisor: Mirum
Speakers Bureau: Ipsen
Patrick G. Northup, MD, FAASLD:
Nothing to Disclose.
Jacqueline G. O'Leary, MD, MPH:
Scientific Consultant/Advisor: Genfit, Grifols, AbbVie, Gilead, Mallinckrodt, Astellas, NovoNordisk, Cellion, Pharmaln
Maura O'Neil, BS, MD
Nothing to Disclose.
Arun Rangaswami, MD:
Nothing to Disclose.
Mary E. Rinella, MD:
Scientific Consultant/Advisor: Boehringer Ingelheim, Intercept Pharmaceuticals, GlaxoSmithKline, Eli Lilly & Co., Inc., Madrigal, NovoNordisk, Cytodyn, HistoIndex, Sonic Incytes, Takeda Pharmaceuticals
Michael Schilsky, MD, FAASLD:
Scientific Consultant: Depymed, Arbormed, Biovie, Salix
Shimul A. Shah, MD:
Scientific Consultant: Veloxis
Research Grants: Organ Recovery Systems, CareDx, AstraZeneca
James E. Squires MD, MS:
Scientific Consultant/Advisor: UpToDate
Data Safety Monitoring Board: Sanofi
Rise Stribling, MD:
Nothing to Disclose.
Tamar H. Taddei, MD:
Nothing to Disclose.
Norah Terrault, MD, MPH, FAASLD:
Data Safety Monitoring Board: Moderna (ended July 2022)
Scientific Consultant/Advisor: CCO Hepatitis, CLDF, Gilead Sciences (ended in 2022)
Richard J. Thompson, MD, PhD, FAASLD:
Scientific Consultant/Advisor: Mirum, Rectify, Shire, Albireo, Qing Bio Therapeutics, GenerationBio, Alnylam, Integra, Ipsen
Stock Options: GenerationBio
Data Safety Monitoring Board: Spruce
John M. Vierling, MD, FACP, FAASLD, AGAF:
Employee: Athenex, Inc.
Scientific Consultant/Advisor: AbbVie, Alexion, Arena, Blade, BristolMyers Squibb, CymaBay, Gilead, Durect, First Thoughts, Fractal, Ipsen, Kezar, LabCorp, Eli Lilly & Co., Inc., Madrigal, Mallinckrodt, Merck & Co., Inc, Moderna, New Horizons, Novartis, Ocalot Bio, SciGen, Takeda, Umecrine, HepQuant, UpToDate
Research Grant: AbbVie, Allergan, Alnlaym, Arena, Arrowhead, 89Bio, Blade, Celgene, Bristol Myers-Squibb, Conatus, CymaBay, Eiger, Eisai, Enanta, Escient, Evive, Galectant, Pfizer, Inc, Pliant, Protagonist, Sagamet, Sundise, Taiwan J, Tobira, Zydus
Michael Volk, MD, MSc, FAASLD:
Scientific Consultant/Advisor: BioVie, Inc.
Speakers Bureau: Salix